XML 84 R52.htm IDEA: XBRL DOCUMENT v3.24.0.1
Restructuring (Tables)
12 Months Ended
Dec. 31, 2023
Restructuring and Related Activities [Abstract]  
Summary of Severance Charges and Associated Spending
The following table summarizes the restructuring expenses for the fiscal year 2023:
(Pre-tax Dollars in Millions)2023
Innovative Medicine Segment(1)
$479
MedTech Segment(2)
319
Total Programs$798
(1)Included $449 million in Restructuring and $30 million in Cost of products sold on the Consolidated Statement of Earnings
(2)Included $40 million in Restructuring and $279 million in Cost of products sold on the Consolidated Statement of Earnings